Hostname: page-component-7c8c6479df-8mjnm Total loading time: 0 Render date: 2024-03-28T15:20:57.769Z Has data issue: false hasContentIssue false

Studies with vitamin E and β-carotene as single agents do not prove lack of benefit

Published online by Cambridge University Press:  01 November 2007

Raymond A. Firestone*
Affiliation:
Boehringer Ingelheim Pharmaceuticals900 Ridgebury RoadPO Box 368RidgefieldCT 06877-0368USA email rfiresto@rdg.boehringer-ingelheim.com
Rights & Permissions [Opens in a new window]

Abstract

Type
Letter to the Editor
Copyright
Copyright © The Author 2007

Recent articles in the British Journal of Nutrition Reference Hercberg, Czernichow and Galan1 and elsewhere2 highlight the paradox that foods rich in vitamin E and β-carotene confer resistance to cancer and heart diseaseReference Hu, Reuben, Crimmins, Harris, Huang and Seeman3Reference Diplock10, but diets enriched with the single-agent α-tocopherol (usually dl) or β-carotene do not, and can even be harmfulReference Hercberg, Czernichow and Galan1, 11Reference Duffield-Lillico and Begg16. Perhaps these substances, present in foods not as single agents but mixed with a large group of similar compounds, are not beneficial in themselves, but act only as markers for other members of their groups that provide the true benefit. This seems unlikely, however. Rather it is likely that the human body, exposed for millennia to mixtures of all eight tocopherols and tocotrienols and all the numerous carotene-like substances, responds properly only to the natural mixtures, and that taking a high dose of any single agent can upset the biochemical balance amongst these components. Furthermore, when dl-α-tocopherol is used, only half of it, the d isomer, is beneficial. Thus, results with natural mixed tocopherols–tocotrienols or carotenes might well be superior to those with single-agent α-tocopherol or β-carotene. Indeed, some recent human studies report that γ-tocopherolReference Friedrich17Reference Helzlsouer, Huang, Alberg, Hoffman, Burke, Norkus, Morris and Comstock20, α-tocotrienolReference Osakada, Hashino, Kune, Katsuki, Kaneko and Akaike21, mixed tocopherolsReference Jiang, Wong, Fyrst, Saba and Ames22 (or α-carotene)Reference Tamimi, Hankinson, Campos, Spiegelman, Zhang, Colditz and Willett23 can equal or even surpass α-tocopherol (or β-carotene) in activity. Moreover, α-tocopherol is a double-edged sword. In the study by Hercberg et al. Reference Hercberg, Czernichow and Galan1 the potential of α-tocopherol for prooxidative behaviour and for disrupting the natural balance of antioxidative substances was noted in passing, but had no influence on the study's design, or conclusions that vitamin E does not prevent cancer or CVD. Although it is widely taken to be a (lipid-soluble) antioxidant, this is true only in the presence of an aqueous phase containing vitamin CReference Sato, Niki and Shimasaki24. Without vitamin C, α-tocopherol becomes a prooxidant, i.e. it promotes oxidative degradation of LDLReference Bowry and Ingold25, a harmful rather than beneficial process. Apparently, unless they are first quenched by vitamin C, tocopheryl radicals are capable of initiating new oxidative radical chains. Therefore it is essential that all subjects in vitamin E dietary studies be replete with vitamin C at all times, which is rarely done. This problem is obviously magnified when supernormal doses of vitamin E (> about 50 IU/d) are given.

The upshot of these considerations is that there is really no paradox, and that only studies involving complete natural mixtures of vitamin E (ensuring repletion with vitamin C at all times) and β-carotene congeners can determine their efficacy in cancer or heart disease.

References

1Hercberg, S, Czernichow, S & Galan, P (2006) Antioxidant vitamins and minerals in prevention of cancers: lessons from the SU.VI.MAX study. Brit J Nutr 96, S28S30.CrossRefGoogle ScholarPubMed
2HOPE trial investigators (2005) Effects of long-term vitamin E supplementation on cardiovascular events and cancer. J Am Med Assoc 293, 13381387.CrossRefGoogle Scholar
3Hu, PF, Reuben, DB, Crimmins, EM, Harris, TB, Huang, MH & Seeman, TE (2004) The effects of serum β-carotene concentration and burden of inflammation on all-cause mortality risk in high-functioning older persons: MacArthur studies of successful aging. J Gerontol Ser A 59, 849854.CrossRefGoogle Scholar
4Miwa, K, Okinaga, S & Fujita, M (2004) Low serum α-tocopherol concentrations in subjects with various coronary risk factors. Circulation J 68, 542546.CrossRefGoogle ScholarPubMed
5Steinmetz, KA & Potter, JD (1991) Vegetables, fruit and cancer. I. Epidemiology. Cancer Causes Control 2, 325357.CrossRefGoogle ScholarPubMed
6Peto, R, Doll, R, Buckley, JD & Sporn, MB (1981) Can dietary β-carotene materially reduce human cancer rates? Nature 290, 201208.CrossRefGoogle ScholarPubMed
7Ito, Y, Wakai, K, Suzuki, K, Tamakoshi, A, Seki, N, Ando, M, Nishino, Y & Ishibashi, T (2003) Serum carotenoids and mortality from lung cancer: a case-control study nested in the Japan Collaborative Cohort (JACC) study. Cancer Sci 94, 5763.CrossRefGoogle ScholarPubMed
8Satia-Abouta, J, Galanko, JA, Martin, CF, Potter, JD, Ammerman, A & Sandler, RS (2003) Associations of micronutrients with colon cancer risk in African Americans and whites: Results from the North Carolina colon cancer study. β-carotene & others reduce colon cancer. Can Epidem Biomark Prev 12, 747754.Google Scholar
9Taylor, PR (2003) Prospective study of serum vitamin E levels and esophageal and gastric cancers. J Nat Can Inst 95, 1414.CrossRefGoogle ScholarPubMed
10Diplock, AT (1987) Dietary supplementation with antioxidants. Is there a case for exceeding the recommended dietary allowance? Free Rad Biol Med 3, 199–201.CrossRefGoogle Scholar
11HOPE trail investigators (2000) Vitamin E supplementation and cardiovascular events in high-risk patients. New Engl J Med 342, 154–160.CrossRefGoogle Scholar
12Vivekanathan, DP, Penn, MS, Sapp, SK, Hsu, A & Topol, EJ (2003) Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomized trials. Lancet 361, 20172023.CrossRefGoogle Scholar
13Kushi, LH, Folsom, AR, Prineas, RJ, Mink, PJ, Wu, Y & Bostick, RM (1996) Dietary antioxidant vitamins and death from coronary heart disease in postmenopausal women. New Engl J Med 334, 1156–1162.CrossRefGoogle ScholarPubMed
14Rapola, JM, Virtamo, J, Ripatti, S, Huttunen, JK, Albanes, D, Taylor, PR & Heinonen, OP (1997) Randomised trial of α-tocopherol and β-carotene supplements on incidence of major coronary events in men with previous myocardial infarction. Lancet 349, 17151720.CrossRefGoogle ScholarPubMed
15Rodriguez, C (2004) Vitamin E supplements and risk of prostate cancer in US men. Can Epidemiol Biomark Prev 13, 378–382.CrossRefGoogle ScholarPubMed
16Duffield-Lillico, AJ & Begg, CB (2004) Reflections on the landmark studies of β-carotene supplementation. J Nat Cancer Inst 96, 17291731.CrossRefGoogle ScholarPubMed
17Friedrich, MJ (2004) To E or not to E, vitamin E's role in health and disease is the question. J Am Med Assoc 292, 671–673.Google Scholar
18Weinstein, SJ, Wright, ME, Pietinen, P, King, I, Tan, C, Taylor, PR, Virtamo, J & Albanes, D (2005) Serum α-tocopherol and γ-tocopherol in relation to prostate cancer risk in a prospective study. J Nat Cancer Inst 97, 396–399.CrossRefGoogle ScholarPubMed
19Wagner, KH, Kamal-Eldin, A & Elmadfa, I (2004) γ-Tocopherol - an underestimated vitamin? Ann Nutr Metab 48, 169–188.CrossRefGoogle ScholarPubMed
20Helzlsouer, KJ, Huang, HY, Alberg, AJ, Hoffman, S, Burke, A, Norkus, EP, Morris, S & Comstock, GW (2000) Association between α-tocopherol, γ-tocopherol, selenium, and subsequent prostate cancer. J Nat Cancer Inst 92, 20182023.CrossRefGoogle ScholarPubMed
21Osakada, F, Hashino, A, Kune, T, Katsuki, H, Kaneko, S & Akaike, A (2004) α-Tocotrienol provides the most important neuroprotection among vitamin E analogs on cultured striatal neurons. Neuropharmacol 47, 904–915.CrossRefGoogle Scholar
22Jiang, Q, Wong, J, Fyrst, H, Saba, JD & Ames, BN (2004) γ-Tocopherol or combinations of vitamin E forms induce cell death in human prostate cancer cells by interrupting sphingolipid synthesis. Proc Nat Acad Sci USA 101, 1782517830.CrossRefGoogle ScholarPubMed
23Tamimi, RM, Hankinson, SE, Campos, H, Spiegelman, D, Zhang, S, Colditz, GA & Willett, WC (2005) Plasma carotenoids, retinol, and tocopherols and risk of breast cancer. Am J Epidemiol 161, 153–160.CrossRefGoogle ScholarPubMed
24Sato, K, Niki, E & Shimasaki, H (1990) Free radical-mediated chain oxidation of low density lipoprotein and its synergistic inhibition by vitamin E and vitamin C. Arch Biochem Biophys 279, 402405.CrossRefGoogle ScholarPubMed
25Bowry, VW & Ingold, KU (1999) The unexpected role of vitamin E (α-tocopherol) in the peroxidation of human low-density lipoprotein. Acc Chem Res 32, 27–34.CrossRefGoogle Scholar